PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt

PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt

ID:208177

大小:289.50 KB

页数:48页

时间:2017-07-03

PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt_第1页
PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt_第2页
PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt_第3页
PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt_第4页
PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt_第5页
资源描述:

《PROVE-IT TIMI-22,A to Z ,RIO-EUROPE研究PPT课件.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、ESC2004: LearningasajourneyValentinFusterMDDirector,CardiovascularInstituteMountSinaiMedicalCenterNewYork,NYChristopherCannonMDStaffcardiologistBrighamandWomen’sHospitalBoston,MAJamesFergusonMDAssociateDirector,CardiologyStLuke'sEpiscopalHospitalandTexasHeartInstituteHouston,TXM

2、ichaelWeberMDProfessorofMedicineSUNYDownstateCollegeofMedicineBrooklyn,NYPROVE-ITTIMI-22PravastatinoratorvastatinevaluationandinfectiontherapyAtoZAggrastattoZocorRIO-EUROPERimonabantinObesity-EuropeTopicsPravastatinorAtorvastatinEvaluationandInfectionTherapyPROVE-ITTIMI-22PROVE-

3、IT:BackgroundPreviousstudieshaveshownthatpatientswithhightitersofChlamydiapneumoniaeatgreaterriskofMIPROVE-ITTIMI-22andACESpresentedatESC2004PROVE-IT:DesignLong-termstudyofantibiotictherapyagainstChlamydiapneumoniaeontheoccurrenceofcardiovasculareventsinpatientswithcoronaryheart

4、disease4162patientswithACS(<10days)Pravastatin(40mgdaily)vsatorvastatin(80mgdaily)Patientswererandomizedasecondtimetoreceivetreatmentwitheithergatifloxacin400mg/dayforafullcourseof10dayspermonthfollowedby20dayswithouttreatmentorplaceboRepeatedeachmonthfortwoyearsPROVEIT-TIMI22:C

5、VDeventsbytreatmentgroupCannonC.ESCCongress2004;August28-September1,2004;Munich,GermanyEndpointGatifloxacinPlaceboHazardriskreduction(95%CI)PCVevents(%)23.725.15(16,-8)0.41Primaryendpointacompositeofall-causemortality,MI,unstableanginarequiringhospitalization,revascularization,a

6、ndstrokePROVE-IT:Greathope“Ithinkit’sasolid‘no’thatthisdoesn’twork.”CannonPROVE-IT:Nobenefit“We’vebeenatthisantibioticquestionacoupleoftimes.”Cantheseresultsbeextendedtopatientswhohavelessatheroscleroticburden?Forpatientswithestablishedcoronarydisease,three “resoundingstudies” s

7、uggestnobenefitFergusonACES:DesignStudycomparedtreatmentwithazithromycin600mgonceaweekforayearwithplaceboin4012patientswithestablishedcoronarydiseasePatientswerethenfollowedforfouryearsfortheoccurrenceofprimaryendpointevents,anyoneofCHDdeath,nonfatalMI,coronaryrevascularization,

8、orhospitalizationforunstableanginaRESULTSPrimar

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。